Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › fruquintinib

fruquintinib

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fruquintinib

3 trials tracked of fruquintinib: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 350 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2
  1. Phase 3 A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer Completed · 350 cited
  2. Phase 2 Study of Fruquintinib in Patients With Metastatic Colorectal Cancer Completed
  3. Phase 2 Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
TAS-102 plus bevacizumab and fruquintinib significantly improve overall survival in metastatic colorectal cancer
Oncology Meta-analysis
TAS-102 plus bevacizumab and fruquintinib significantly improve overall survival in metastatic colorectal cancer Fruquintinib and TAS-102 Show Promise for Metastatic Colorectal Cancer
This systematic review and network meta-analysis of 3959 patients evaluated several treatments for metastatic colorectal cancer. The analysi…
New analysis shows fruquintinib and TAS-102 plus bevacizumab can improve survival for patients with metastatic colorectal cancer.
Frontiers Oct 16, 2026
Traditional Chinese medicine may modulate immune resistance barriers in microsatellite-stable colorectal cancer
Oncology Sys. Review
Traditional Chinese medicine may modulate immune resistance barriers in microsatellite-stable colorectal cancer Traditional Chinese medicine may help some patients with colorectal cancer
This narrative review explores the role of traditional Chinese medicine (TCM) in overcoming immune-resistance mechanisms in patients with mi…
New research explores how traditional herbal medicines might help overcome treatment resistance in a specific type of colorectal cancer.
Frontiers Jul 3, 2026